Search

Post CLABSI antimicrobial de-escalation

“An institutional protocol was developed for the evaluation and empirical antibiotic treatment of possible CLABSIs. The potential impact of de-escalating antimicrobial therapy based on initial Gram stain and molecular identification was assessed” Beckman et al (2024).

Read More »

Implantable port site complications post bevacizumab infusion

“The results of this study show an inverse relationship between the risk of wound dehiscence and port site complication and the timing of bevacizumab infusion to port placement, with an increase in absolute risk of wound dehiscence when bevacizumab is given within 2 days of port placement” Yun et al (2024).

Read More »

Proposal for the development of German central venous access guidelines

“In our opinion, the most needed recommendation for central venous access is to utilize ultrasound guidance, a practice that many international societies have already incorporated into their published national guidelines. In our view, it is time to implement a national guideline for central venous access using ultrasound in Germany” Armbruster et al (2024).

Read More »

Mycobacterium senegalense CLABSI diagnosis and management

“Blood cultures from a permanent catheter and peripheral taken concurrently yielded Mycobacterium senegalense, identified by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry, which established the diagnosis of CRBSI atypically presented with concurrent acute intracranial bleeding and cerebrovascular infarction at initial presentation” Badarol Hisham et al (2024).

Read More »

OPAT patient experience in Germany – Full Text

“Because OPAT has been used only sporadically in Germany so far, no structured results on patients’ experiences and concerns regarding OPAT have yet been available. This study therefore aims to explore the experiences of OPAT patients in a pilot region in Germany” Oberröhrmann et al (2024).

Read More »

Combination systemic and catheter lock-therapy – Full Text

“The study demonstrates that combining systemic and lock therapies with micafungin effectively eradicates catheter-based biofilms and infections caused by C. albicans or C. parapsilosis, particularly in persistently neutropenic conditions, offering promising implications for managing vascular catheter-related candidemia and providing clinical benefits in cases where catheter removal is not feasible” Petraitiene et al (2024).

Read More »

Pharmacist role in OPAT – Full Text

“The TOC pharmacists can play a key role in the evaluation of OPAT prescriptions at hospital discharge. This intervention demonstrated how TOC pharmacists can effectively collaborate with the OPAT team, which builds on prior evidence of the role and value of pharmacists in the transitional care setting” Stashluk et al (2024).

Read More »

Post CLABSI antimicrobial de-escalation

“An institutional protocol was developed for the evaluation and empirical antibiotic treatment of possible CLABSIs. The potential impact of de-escalating antimicrobial therapy based on initial Gram stain and molecular identification was assessed” Beckman et al (2024).

Read More »

Implantable port site complications post bevacizumab infusion

“The results of this study show an inverse relationship between the risk of wound dehiscence and port site complication and the timing of bevacizumab infusion to port placement, with an increase in absolute risk of wound dehiscence when bevacizumab is given within 2 days of port placement” Yun et al (2024).

Read More »

Proposal for the development of German central venous access guidelines

“In our opinion, the most needed recommendation for central venous access is to utilize ultrasound guidance, a practice that many international societies have already incorporated into their published national guidelines. In our view, it is time to implement a national guideline for central venous access using ultrasound in Germany” Armbruster et al (2024).

Read More »

Mycobacterium senegalense CLABSI diagnosis and management

“Blood cultures from a permanent catheter and peripheral taken concurrently yielded Mycobacterium senegalense, identified by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry, which established the diagnosis of CRBSI atypically presented with concurrent acute intracranial bleeding and cerebrovascular infarction at initial presentation” Badarol Hisham et al (2024).

Read More »

OPAT patient experience in Germany – Full Text

“Because OPAT has been used only sporadically in Germany so far, no structured results on patients’ experiences and concerns regarding OPAT have yet been available. This study therefore aims to explore the experiences of OPAT patients in a pilot region in Germany” Oberröhrmann et al (2024).

Read More »

Combination systemic and catheter lock-therapy – Full Text

“The study demonstrates that combining systemic and lock therapies with micafungin effectively eradicates catheter-based biofilms and infections caused by C. albicans or C. parapsilosis, particularly in persistently neutropenic conditions, offering promising implications for managing vascular catheter-related candidemia and providing clinical benefits in cases where catheter removal is not feasible” Petraitiene et al (2024).

Read More »

Pharmacist role in OPAT – Full Text

“The TOC pharmacists can play a key role in the evaluation of OPAT prescriptions at hospital discharge. This intervention demonstrated how TOC pharmacists can effectively collaborate with the OPAT team, which builds on prior evidence of the role and value of pharmacists in the transitional care setting” Stashluk et al (2024).

Read More »

CLABSI prevention survey

“Most US hospitals continue to use evidence-based methods to prevent CLABSI as recommended by leading organizations. Opportunities to focus on socio-adaptive interventions such as feedback of infection rates, use of appropriateness criteria for CVC placement, and improving the “culture of pan-culturing” remain” Pisney et al (2024).

Read More »

Needleless connector flow rates

“In this study we utilised a rapid infuser to deliver room-temperature normal saline through two introducer sheath configurations with and without the addition of needleless connectors and the placement of catheters through the introducer sheaths” Smeltz et al (2024).

Read More »

Intravenous iron infusions in pediatric patients

“This single-institution retrospective chart review was conducted to assess the safety, efficacy, and adherence of intravenous (IV) iron infusions compared to oral iron in pediatric patients who had failed a trial of oral iron supplementation” Strachan et al (2024).

Read More »